COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study
1 other identifier
observational
314
1 country
1
Brief Summary
COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study. All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020- 30/5/2020 \& prospective data from approval till 30/6/2020), will be included
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2020
CompletedStudy Start
First participant enrolled
June 7, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedJune 9, 2020
June 1, 2020
2 months
June 7, 2020
June 7, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
COVID-19 Positive Case
To study the prevalence of liver live injury \& factors associated with among patients in-fected with SARS-CoV-2.
4-8 weeks
COVID-19 Positive Case
To study the prevalence of new liver injury and factors associated with it, among patient with underlying liver disease who develops COVID-19.
4-8 weeks
Secondary Outcomes (2)
COVID-19 Positive Case
4-8 weeks
COVID-19 Positive Case
4-8 weeks
Eligibility Criteria
The study population will include all the COVID 19 patients (male \& female) with minimum age 18 years old. And take 60% patient in Retrospective arm and 40% patient in prospective arm.
You may not qualify if:
- Patients less that 18 years old with COVID-19
- Pregnant ladies with COVD-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Max Super Speciality Hospital, Saket (A Unit Of Devki Devi Foundation)
New Delhi, Dlelhi, 110017, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kaushal Madan, DM
Max healthcare
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2020
First Posted
June 9, 2020
Study Start
June 7, 2020
Primary Completion
July 30, 2020
Study Completion
August 30, 2020
Last Updated
June 9, 2020
Record last verified: 2020-06